help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ong, H.
Right arrow Articles by Nilsson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ong, H.
Right arrow Articles by Nilsson, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Endocrinology Vol. 139, No. 1 432-435
Copyright © 1998 by The Endocrine Society

ARTICLES

Identification of a Pituitary Growth Hormone-Releasing Peptide (GHRP) Receptor Subtype by Photoaffinity Labeling

H. Ong, N. McNicoll, E. Escher, R. Collu, R. Deghenghi, V. Locatelli, E. Ghigo, G. Muccioli, M. Boghen and M. Nilsson

Faculty of Pharmacy (H.O., N.McN.) and Ste-Justine Hospital (R.C.), University of Montréal, Montréal, Canada; Department of Pharmacology (E.E.), University of Sherbrooke, Sherbrooke, Canada; Europeptides (R.D.), Argenteuil, France; Department of Pharmacology (V.L.), University of Milan, Milan, Italy; Department of Internal Medecine (E.G.) and Department of Anatomy (G.M.), University of Turin, Turin, Italy; Pharmacia & Upjohn (M.B., M.N.), Stockholm, Sweden

Address all correspondence and requests for reprints to: Dr. Huy Ong, Université de Montréal, Faculté de Pharmacie, C.P. 6128, Succ. Centre-Ville, Montréal, Québec H3C 3J7, Canada.


   Abstract
Top
 Abstract
 
Hexarelin, an analogue of GHRP-6, in which D-Tryptophan has been replaced by its 2-methyl derivative, is known to release growth hormone (GH) in vivo and in vitro by direct action on receptors present in anterior pituitary cells. Measurement of second messengers (c-AMP, Ca++, IP3) upon somatotrophs stimulation, suggests the existence of more than one GHRP receptor subtype. In order to document such an hypothesis, we have used a new photoactivatable derivative of Hexarelin, Tyr-Bpa-Ala-Hexarelin. This derivative was shown to be fully active in the release of GH in vivo with neonate rats. Using this photoactivatable ligand, we have specifically labeled a protein with an apparent Mr of 57 000 in human, bovine and porcine anterior pituitary membranes. Hexarelin and the spiroindoline sulfonamide MK-0677 displaced the Mr -57 000 photolabeled band with an apparent ED50 of 6x10-7 M and 2x10-5 M respectively. Taking into account the high efficiency (>60%) of covalent incorporation of the Bpa residue, this photoactivatable Hexarelin derivative has allowed the identification of a pituitary GHRP receptor subtype, which is apparently distinct from the recently cloned GH secretagogue receptor.

Received July 16, 1997.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
I. Johansson, S. Destefanis, N. D. Aberg, M. A. I. Aberg, K. Blomgren, C. Zhu, C. Ghe, R. Granata, E. Ghigo, G. Muccioli, et al.
Proliferative and Protective Effects of Growth Hormone Secretagogues on Adult Rat Hippocampal Progenitor Cells
Endocrinology, May 1, 2008; 149(5): 2191 - 2199.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. M. Luque, R. D. Kineman, S. Park, X.-D. Peng, F. Gracia-Navarro, J. P. Castano, and M. M. Malagon
Homologous and Heterologous Regulation of Pituitary Receptors for Ghrelin and Growth Hormone-Releasing Hormone
Endocrinology, July 1, 2004; 145(7): 3182 - 3189.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
Endocr. Rev., June 1, 2004; 25(3): 426 - 457.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. M. Malagon, R. M. Luque, E. Ruiz-Guerrero, F. Rodriguez-Pacheco, S. Garcia-Navarro, F. F. Casanueva, F. Gracia-Navarro, and J. P. Castano
Intracellular Signaling Mechanisms Mediating Ghrelin-Stimulated Growth Hormone Release in Somatotropes
Endocrinology, December 1, 2003; 144(12): 5372 - 5380.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. R. Cunha and K. E. Mayo
Ghrelin and Growth Hormone (GH) Secretagogues Potentiate GH-Releasing Hormone (GHRH)-Induced Cyclic Adenosine 3',5'-Monophosphate Production in Cells Expressing Transfected GHRH and GH Secretagogue Receptors
Endocrinology, December 1, 2002; 143(12): 4570 - 4582.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
V. Bodart, M. Febbraio, A. Demers, N. McNicoll, P. Pohankova, A. Perreault, T. Sejlitz, E. Escher, R.L. Silverstein, D. Lamontagne, et al.
CD36 Mediates the Cardiovascular Action of Growth Hormone-Releasing Peptides in the Heart
Circ. Res., May 3, 2002; 90(8): 844 - 849.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Ghe, P. Cassoni, F. Catapano, T. Marrocco, R. Deghenghi, E. Ghigo, G. Muccioli, and M. Papotti
The Antiproliferative Effect of Synthetic Peptidyl GH Secretagogues in Human CALU-1 Lung Carcinoma Cells
Endocrinology, February 1, 2002; 143(2): 484 - 491.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Garcia, C. V. Alvarez, R. G. Smith, and C. Dieguez
Regulation of PIT-1 Expression By Ghrelin and GHRP-6 Through the GH Secretagogue Receptor
Mol. Endocrinol., September 1, 2001; 15(9): 1484 - 1495.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Petersenn, A. C. Rasch, M. Penshorn, F. U. Beil, and H. M. Schulte
Genomic Structure and Transcriptional Regulation of the Human Growth Hormone Secretagogue Receptor
Endocrinology, June 1, 2001; 142(6): 2649 - 2659.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Cassoni, M. Papotti, C. Ghè, F. Catapano, A. Sapino, A. Graziani, R. Deghenghi, T. Reissmann, E. Ghigo, and G. Muccioli
Identification, Characterization, and Biological Activity of Specific Receptors for Natural (Ghrelin) and Synthetic Growth Hormone Secretagogues and Analogs in Human Breast Carcinomas and Cell Lines
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1738 - 1745.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Arvat, M. Maccario, L. Di Vito, F. Broglio, A. Benso, C. Gottero, M. Papotti, G. Muccioli, C. Dieguez, F. F. Casanueva, et al.
Endocrine Activities of Ghrelin, a Natural Growth Hormone Secretagogue (GHS), in Humans: Comparison and Interactions with Hexarelin, a Nonnatural Peptidyl GHS, and GH-Releasing Hormone
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1169 - 1174.
[Abstract] [Full Text]

Home page
 DiabetesHome page
M. Shintani, Y. Ogawa, K. Ebihara, M. Aizawa-Abe, F. Miyanaga, K. Takaya, T. Hayashi, G. Inoue, K. Hosoda, M. Kojima, et al.
Ghrelin, an Endogenous Growth Hormone Secretagogue, Is a Novel Orexigenic Peptide That Antagonizes Leptin Action Through the Activation of Hypothalamic Neuropeptide Y/Y1 Receptor Pathway
Diabetes, February 1, 2001; 50(2): 227 - 232.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Papotti, C. Ghè, P. Cassoni, F. Catapano, R. Deghenghi, E. Ghigo, and G. Muccioli
Growth Hormone Secretagogue Binding Sites in Peripheral Human Tissues
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3803 - 3807.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
S. Tullin, B. S. Hansen, M. Ankersen, J. Moller, K. A. von Cappelen, and L. Thim
Adenosine Is an Agonist of the Growth Hormone Secretagogue Receptor
Endocrinology, September 1, 2000; 141(9): 3397 - 3402.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Tivesten, E. Bollano, K. Caidahl, V. Kujacic, X. Y. Sun, T. Hedner, A. Hjalmarson, B.-A. Bengtsson, and J. Isgaard
The Growth Hormone Secretagogue Hexarelin Improves Cardiac Function in Rats after Experimental Myocardial Infarction
Endocrinology, January 1, 2000; 141(1): 60 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
V. Bodart, J. F. Bouchard, N. McNicoll, E. Escher, P. Carriere, E. Ghigo, T. Sejlitz, M. G. Sirois, D. Lamontagne, and H. Ong
Identification and Characterization of a New Growth Hormone-Releasing Peptide Receptor in the Heart
Circ. Res., October 29, 1999; 85(9): 796 - 802.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. Locatelli, G. Rossoni, F. Schweiger, A. Torsello, V. De Gennaro Colonna, M. Bernareggi, R. Deghenghi, E. E. Müller, and F. Berti
Growth Hormone-Independent Cardioprotective Effects of Hexarelin in the Rat
Endocrinology, September 1, 1999; 140(9): 4024 - 4031.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Shah, W. S. Evans, C. Y. Bowers, and J. D. Veldhuis
Tripartite Neuroendocrine Activation of the Human Growth Hormone (GH) Axis in Women by Continuous 24-Hour GH-Releasing Peptide Infusion: Pulsatile, Entropic, and Nyctohemeral Mechanisms
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2140 - 2150.
[Abstract] [Full Text]

Home page
 Physiol. Rev.Home page
E. E. Muller, V. Locatelli, and D. Cocchi
Neuroendocrine Control of Growth Hormone Secretion
Physiol Rev, April 1, 1999; 79(2): 511 - 607.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Ghigo, L. Gianotti, E. Arvat, J. Ramunni, M. R. Valetto, F. Broglio, M. Rolla, F. Cavagnini, and E. E. Müller
Effects of Recombinant Human Insulin-Like Growth Factor I Administration on Growth Hormone (GH) Secretion, Both Spontaneous and Stimulated by GH-Releasing Hormone or Hexarelin, a Peptidyl GH Secretagogue, in Humans
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 285 - 290.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
A. Giustina and J. D. Veldhuis
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human
Endocr. Rev., December 1, 1998; 19(6): 717 - 797.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Arvat, R. Giordano, J. Ramunni, G. Arnaldi, A. Colao, R. Deghenghi, G. Lombardi, F. Mantero, F. Camanni, and E. Ghigo
Adrenocorticotropin and Cortisol Hyperresponsiveness to Hexarelin in Patients with Cushing's Disease Bearing a Pituitary Microadenoma, But Not in Those with Macroadenoma
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4207 - 4211.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
V. Bodart, M. Febbraio, A. Demers, N. McNicoll, P. Pohankova, A. Perreault, T. Sejlitz, E. Escher, R.L. Silverstein, D. Lamontagne, et al.
CD36 Mediates the Cardiovascular Action of Growth Hormone-Releasing Peptides in the Heart
Circ. Res., May 3, 2002; 90(8): 844 - 849.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ong, H.
Right arrow Articles by Nilsson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ong, H.
Right arrow Articles by Nilsson, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals